MAFFEI, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.115
AS - Asia 3.446
EU - Europa 3.257
SA - Sud America 428
AF - Africa 87
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.999
GB - Regno Unito 1.034
SG - Singapore 949
HK - Hong Kong 793
CN - Cina 792
IT - Italia 595
VN - Vietnam 413
SE - Svezia 368
DE - Germania 337
BR - Brasile 323
FI - Finlandia 197
RU - Federazione Russa 166
UA - Ucraina 135
FR - Francia 122
TR - Turchia 98
IN - India 72
CA - Canada 62
KR - Corea 60
BG - Bulgaria 51
ID - Indonesia 49
BD - Bangladesh 40
NL - Olanda 40
AU - Australia 38
ES - Italia 38
IE - Irlanda 30
AR - Argentina 29
JP - Giappone 27
ZA - Sudafrica 27
BE - Belgio 26
IQ - Iraq 24
PL - Polonia 23
MX - Messico 22
CL - Cile 20
CZ - Repubblica Ceca 19
AE - Emirati Arabi Uniti 17
PK - Pakistan 17
MA - Marocco 16
PH - Filippine 15
VE - Venezuela 14
EC - Ecuador 13
UZ - Uzbekistan 13
AT - Austria 11
RO - Romania 11
CO - Colombia 10
MY - Malesia 10
DK - Danimarca 9
JO - Giordania 9
KE - Kenya 9
LT - Lituania 8
CH - Svizzera 7
JM - Giamaica 7
PY - Paraguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
SA - Arabia Saudita 6
BZ - Belize 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
TW - Taiwan 5
BO - Bolivia 4
GR - Grecia 4
PE - Perù 4
SN - Senegal 4
TN - Tunisia 4
AL - Albania 3
BY - Bielorussia 3
CY - Cipro 3
HR - Croazia 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
PR - Porto Rico 3
QA - Qatar 3
RS - Serbia 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
KW - Kuwait 1
LV - Lettonia 1
Totale 15.362
Salva come PNG Salva come JPEG
Città #
Ann Arbor 792
Hong Kong 789
Fairfield 784
Ashburn 746
Southend 733
Santa Clara 615
Singapore 566
Woodbridge 469
Houston 416
Chandler 413
Seattle 312
Cambridge 272
Wilmington 244
Nyköping 243
Jacksonville 215
San Jose 203
Hefei 199
Dearborn 196
Chicago 152
Beijing 151
Helsinki 147
London 145
Modena 144
Los Angeles 141
Ho Chi Minh City 122
New York 104
Hanoi 98
Council Bluffs 73
Munich 71
The Dalles 67
Salt Lake City 62
San Diego 61
Seoul 58
Fremont 57
Princeton 55
Milan 54
Lauterbourg 51
Sofia 51
Eugene 46
Izmir 45
Moscow 45
Bremen 35
Jakarta 35
Buffalo 32
Tampa 32
Bologna 30
Dublin 30
Dallas 29
Rome 29
Frankfurt am Main 28
Brussels 26
Orem 26
Shanghai 25
São Paulo 25
Atlanta 24
Columbus 24
Elk Grove Village 24
Redwood City 23
Melbourne 22
Phoenix 22
Boardman 20
Miami 20
Warsaw 20
Des Moines 19
Da Nang 18
Lancaster 18
Tokyo 18
Brooklyn 16
Chennai 15
Haiphong 15
Dong Ket 14
Falls Church 14
Montreal 14
Brno 13
Denver 13
Tashkent 13
Toronto 13
Vancouver 13
Amsterdam 11
Dulles 11
Jinan 11
Rio de Janeiro 11
Ankara 10
Baghdad 10
Guangzhou 10
Johannesburg 10
Kent 10
Ninh Bình 10
Perugia 10
Reggio Emilia 10
Turku 10
Boston 9
Kilburn 9
Madrid 9
Poplar 9
San Francisco 9
Santiago 9
Sterling 9
Bari 8
Deventer 8
Totale 11.227
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 821
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 582
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 411
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 406
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 386
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 363
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 353
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 350
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 341
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 331
Mucorales-specific T cells in patients with hematologic malignancies 324
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 324
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 320
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 316
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 315
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 315
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 310
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 303
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 302
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 299
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 299
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 298
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 291
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 291
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 286
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 285
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 284
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 275
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 274
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 273
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 272
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 264
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 263
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 257
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 254
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study 248
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 243
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 241
HOXA homeogene cluster interruption and dysregulation of HOAX9 in the blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. 231
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 228
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 226
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 221
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. 219
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 214
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. 195
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 181
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 176
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. 162
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 162
Performance trade-offs of different rake receivers 153
NOX-A12: Mobilizing CLL away from home 138
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 135
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 108
The dynamic functions of IRF4 in B cell malignancies 98
Totale 15.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021342 0 0 0 0 0 0 0 0 0 152 84 106
2021/20221.057 64 134 93 46 29 82 53 53 97 84 215 107
2022/20231.247 128 156 103 114 168 164 15 145 134 12 53 55
2023/2024800 28 36 51 85 149 68 86 110 15 24 63 85
2024/20252.728 82 49 29 194 409 354 180 135 610 129 217 340
2025/20264.828 337 703 324 594 871 326 613 219 464 377 0 0
Totale 15.476